Literature DB >> 26091636

Safety Pharmacology in Drug Discovery and Development.

Bruce H Morimoto1, Erin Castelloe, Anthony W Fox.   

Abstract

Safety pharmacology is essential throughout the spectrum of drug discovery and development. Prior to first-in-human studies, safety pharmacology assays, tests, and models predict the clinical risk profile of a potential new drug. During clinical development, safety pharmacology can be used to explore--and potentially explain--both predicted and unpredicted side effects (e.g., adverse events, changes in vital signs, abnormal laboratory values) in order to refine the original clinical risk profile. This chapter will introduce the reader to safety pharmacology's role in translational medicine: the science of translating potential drugs' on- and off-target nonclinical properties to clinical consequences in order to select the best drug candidates to move into early clinical testing. Case studies will be used to illustrate the importance of safety pharmacology testing throughout all phases of drug development.

Entities:  

Mesh:

Year:  2015        PMID: 26091636     DOI: 10.1007/978-3-662-46943-9_3

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  4 in total

1.  Physical Properties and Effect in a Battery of Safety Pharmacology Models for Three Structurally Distinct Enteric Polymers Employed as Spray-Dried Dispersion Carriers.

Authors:  Ryan M Fryer; Mita Patel; Xiaomei Zhang; Katja S Baum-Kroker; Akalushi Muthukumarana; Brian Linehan; Yin-Chao Tseng
Journal:  Front Pharmacol       Date:  2016-10-13       Impact factor: 5.810

2.  Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage.

Authors:  Xian Zhang; Nan Zhang; Micah A Chrenek; Preston E Girardot; Jiaxing Wang; Jana T Sellers; Eldon E Geisert; Charles Brenner; John M Nickerson; Jeffrey H Boatright; Ying Li
Journal:  Pharmaceutics       Date:  2021-06-16       Impact factor: 6.321

Review 3.  Ellagic Acid, Kaempferol, and Quercetin from Acacia nilotica: Promising Combined Drug With Multiple Mechanisms of Action.

Authors:  Mosab Yahya Al-Nour; Musab Mohamed Ibrahim; Tilal Elsaman
Journal:  Curr Pharmacol Rep       Date:  2019-05-14

4.  Safety assessment of subtilisin QK in rats.

Authors:  Shuai Xiao; Dingbang Hu; Ya Gao; Yang Ai; Sang Luo; Song Chen; Ben Wang; Li Zhou; Yanshan Dong; Yefu Wang
Journal:  BMC Pharmacol Toxicol       Date:  2021-06-26       Impact factor: 2.483

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.